MoonLake Immunotherapeutics (MLTX)
18.49
+4.15
(+28.94%)
USD |
NASDAQ |
Jan 09, 16:00
19.38
+0.89
(+4.81%)
After-Hours: 20:00
MoonLake Immunotherapeutics Total Assets (Quarterly): 414.34M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Baxter International, Inc. | 21.07B |
| aTyr Pharma, Inc. | 106.65M |
| BeOne Medicines Ltd. | 7.633B |
| AC Immune SA | 215.68M |
| CRISPR Therapeutics AG | 2.245B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 123.14M |
| Shareholders Equity (Quarterly) | 288.91M |
| Debt to Equity Ratio | 0.2621 |
| Current Ratio | 8.502 |
| Net Debt Paydown Yield | -3.17% |